BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22286117)

  • 1. Relationship between atrophy of the medial temporal areas and cognitive functions in elderly adults with mild cognitive impairment.
    Shimada H; Kato T; Ito K; Makizako H; Doi T; Yoshida D; Shimokata H; Washimi Y; Endo H; Suzuki T
    Eur Neurol; 2012; 67(3):168-77. PubMed ID: 22286117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between decline in physical functioning and atrophy of medial temporal areas in community-dwelling older adults with amnestic and nonamnestic mild cognitive impairment.
    Makizako H; Shimada H; Doi T; Yoshida D; Ito K; Kato T; Shimokata H; Washimi Y; Endo H; Suzuki T
    Arch Phys Med Rehabil; 2011 Dec; 92(12):1992-9. PubMed ID: 22133247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of muscle strength with cognitive function and medial temporal lobe atrophy in patients with mild to moderate Alzheimer's disease].
    Liu SW; Li M; Zhu JT; Zhang YC; Wu YH; Liu CF; Hu H
    Zhonghua Yi Xue Za Zhi; 2022 Sep; 102(35):2786-2792. PubMed ID: 36124351
    [No Abstract]   [Full Text] [Related]  

  • 4. Practical cut-offs for visual rating scales of medial temporal, frontal and posterior atrophy in Alzheimer's disease and mild cognitive impairment.
    Ferreira D; Cavallin L; Larsson EM; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Simmons A; Wahlund LO; Westman E;
    J Intern Med; 2015 Sep; 278(3):277-90. PubMed ID: 25752192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior Atrophy and Medial Temporal Atrophy Scores Are Associated with Different Symptoms in Patients with Alzheimer's Disease and Mild Cognitive Impairment.
    Hsu JL; Lee WJ; Liao YC; Lirng JF; Wang SJ; Fuh JL
    PLoS One; 2015; 10(9):e0137121. PubMed ID: 26372372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. White matter microstructural damage and depressive symptoms in patients with mild cognitive impairment and cerebral small vessel disease: the VMCI-Tuscany Study.
    Pasi M; Poggesi A; Salvadori E; Diciotti S; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Mascalchi M; Inzitari D; Pantoni L
    Int J Geriatr Psychiatry; 2016 Jun; 31(6):611-8. PubMed ID: 26489377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timed Up and Go test, atrophy of medial temporal areas and cognitive functions in community-dwelling older adults with normal cognition and mild cognitive impairment.
    Kose Y; Ikenaga M; Yamada Y; Morimura K; Takeda N; Ouma S; Tsuboi Y; Yamada T; Kimura M; Kiyonaga A; Higaki Y; Tanaka H;
    Exp Gerontol; 2016 Dec; 85():81-87. PubMed ID: 27693131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between atrophy of the medial temporal area and daily activities in older adults with mild cognitive impairment.
    Yoshida D; Shimada H; Makizako H; Doi T; Ito K; Kato T; Shimokata H; Washimi Y; Endo H; Suzuki T
    Aging Clin Exp Res; 2012 Oct; 24(5):423-9. PubMed ID: 22395286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
    Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
    Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. White matter microstructural damage in small vessel disease is associated with Montreal cognitive assessment but not with mini mental state examination performances: vascular mild cognitive impairment Tuscany study.
    Pasi M; Salvadori E; Poggesi A; Ciolli L; Del Bene A; Marini S; Nannucci S; Pescini F; Valenti R; Ginestroni A; Toschi N; Diciotti S; Mascalchi M; Inzitari D; Pantoni L;
    Stroke; 2015 Jan; 46(1):262-4. PubMed ID: 25395414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial temporal lobe atrophy and memory deficits in elderly stroke patients.
    Jokinen H; Kalska H; Ylikoski R; Hietanen M; Mäntylä R; Pohjasvaara T; Kaste M; Erkinjuntti T
    Eur J Neurol; 2004 Dec; 11(12):825-32. PubMed ID: 15667413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of progression from mild cognitive impairment to dementia in the placebo-arm of a clinical trial population.
    Prins ND; van der Flier WM; Brashear HR; Knol DL; van de Pol LA; Barkhof F; Scheltens P
    J Alzheimers Dis; 2013; 36(1):79-85. PubMed ID: 23563246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of medial temporal atrophy and amnestic mild cognitive impairment: selecting type and number of memory tests.
    Loewenstein DA; Acevedo A; Potter E; Schinka JA; Raj A; Greig MT; Agron J; Barker WW; Wu Y; Small B; Schofield E; Duara R
    Am J Geriatr Psychiatry; 2009 Dec; 17(12):1050-8. PubMed ID: 20104061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease.
    Kandiah N; Chander RJ; Ng A; Wen MC; Cenina AR; Assam PN
    Eur J Neurol; 2015 Jan; 22(1):150-5. PubMed ID: 25142829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of medial temporal atrophy and white matter hyperintensities on the cognitive functions in patients with Alzheimer's disease.
    Shim YS; Youn YC; Na DL; Kim SY; Cheong HK; Moon SY; Park KW; Ku BD; Lee JY; Jeong JH; Kang H; Kim EJ; Lee JS; Go SM; Kim SH; Cha KR; Seo SW
    Eur Neurol; 2011; 66(2):75-82. PubMed ID: 21778730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between atrophy of the entorhinal cortex and cognitive function in patients with Alzheimer's disease and mild cognitive impairment.
    Li X; Jiao J; Shimizu S; Jibiki I; Watanabe K; Kubota T
    Psychiatry Clin Neurosci; 2012 Dec; 66(7):587-93. PubMed ID: 23252925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study.
    van de Pol LA; Verhey F; Frisoni GB; Tsolaki M; Papapostolou P; Nobili F; Wahlund LO; Minthon L; Frölich L; Hampel H; Soininen H; Knol DL; Barkhof F; Scheltens P; Visser PJ
    J Neurol Neurosurg Psychiatry; 2009 Oct; 80(10):1069-74. PubMed ID: 19541689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combining Visual Rating Scales for Medial Temporal Lobe Atrophy and Posterior Atrophy to Identify Amnestic Mild Cognitive Impairment from Cognitively Normal Older Adults: Evidence Based on Two Cohorts.
    Sheng C; Sun Y; Wang M; Wang X; Liu Y; Pang D; Liu J; Bi X; Du W; Zhao M; Li Y; Li X; Jiang J; Han Y
    J Alzheimers Dis; 2020; 77(1):323-337. PubMed ID: 32716355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medial temporal lobe atrophy, white matter hyperintensities and cognitive impairment among Nigerian African stroke survivors.
    Akinyemi RO; Firbank M; Ogbole GI; Allan LM; Owolabi MO; Akinyemi JO; Yusuf BP; Ogunseyinde O; Ogunniyi A; Kalaria RN
    BMC Res Notes; 2015 Oct; 8():625. PubMed ID: 26519155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.